EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Iron-Based Nanoplatforms Achieve Hepatocellular Carcinoma Regression Through a Cascade of Effects

Kunzhao Huang, Xiaoyuan Yi, Huaying Xie, Jianzhang Luo, Qingyu Zeng, Feifei He, Liyan Wang

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s479425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Kunzhao Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Department, The Affiliated Hospital of Guilin Medical College, Guilin, 541001, People's Republic of China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Ferroptosis is a regulated form of cell death characterized by iron-dependent accumulation of associated lipid peroxides (LPO), which can induce cell death when a certain level is reached. However, the extremely complex tumor microenvironment (TME) has the characteristics of antioxidant, even if it induces ferroptosis of tumor cells, its killing effect on tumor cells is still very limited. To solve this problem, we constructed a novel nanomaterials (GOx/EC@Fe3O4@CCM). We evaluated the anticancer effect of this nanomaterial in inhibiting tumor growth through comprehensive in vitro and in vivo experiments.

Methods

We successfully synthesized GOx/EC@Fe3O4 by one-pan synthesis method, then coated the Hepatocellular carcinoma cell membrane on its surface by co-extrusion technology, and finally synthesized the GOx/EC@Fe3O4@CCM nanoplatforms. We characterized the compounds in terms of morphology, particle size, and Zeta potential. In addition, we also studied the anti-tumor effect of GOx/EC@Fe3O4@CCM nanoplatforms from the following aspects, including the performance test of the nanoplatform, the intracellular effect of the nanoplatform, the anti-tumor effect in vitro, the intracellular ROS analysis, the intracellular effect of EC, and the anti-tumor effect in vivo.

Results

The iron-based carriers in GOx/EC@Fe3O4@CCM nanoplatforms are released and produce ferrous ions (Fe2+) in an acidic environment. Due to the limitation of the endogenous level of hydrogen peroxide (H2O2), we introduced GOx into the TME or tumor cells. Under the catalysis of GOx, glucose reacted rapidly to produce a large amount of H2O2, which then combined with Fe2+ to produce a large number of Hydroxyl radical (·OH). Its toxicity leads to dysfunction of cell membrane and organelles, and then causes cell damage. EC inhibits Nuclear factor erythroid 2-related factor 2 (Nrf2) in cancer cells, which effectively down-regulates downstream gene products, including NAD(P)H quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HMOX1). A series of chain reactions reduce the escape effect of oxidative stress (OS) and effectively maintain a high level of intracellular oxidation. Furthermore, it induces sustained and intense ferroptosis in tumor cells. Finally, the use of cancer cell membrane modified nanoplatforms due to the homology of membrane protein components improves the tumor cell targeting of the nanoplatforms, showing significant tumor cell inhibition and killing effect in vivo.

Conclusion

The results showed that the GOx/EC@Fe3O4@CCM nanoplatforms successfully induced significant ferroptosis of Hepatocellular carcinoma cells through a cascade effect, and finally effectively promoted cancer cell regression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularFerroptosisAnimalsHumansMiceReactive Oxygen SpeciesIronTumor MicroenvironmentCell Line, TumorHep G2 CellsMice, Inbred BALB CMice, NudeAntineoplastic AgentsXenograft Model Antitumor AssaysNF-E2-Related Factor 2

Stichwörter der Autor:innen

Nrf2ethyl carbamateferroptosisglucose oxidasemesoporous Fe3O4

Substanzen

Reactive Oxygen SpeciesIronAntineoplastic AgentsNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Digestive Department, The Affiliated Hospital of Guilin Medical College, Guilin, 541001, People's Republic of China.

Zitieren

APA

Huang, K., Yi, X., Xie, H., Luo, J., Zeng, Q., He, F., & Wang, L. (2024). Iron-Based Nanoplatforms Achieve Hepatocellular Carcinoma Regression Through a Cascade of Effects. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s479425

Vancouver

Huang K, Yi X, Xie H, Luo J, Zeng Q, He F, et al. Iron-Based Nanoplatforms Achieve Hepatocellular Carcinoma Regression Through a Cascade of Effects. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s479425

BibTeX
@article{Huang2024,
  author = {Huang, Kunzhao and Yi, Xiaoyuan and Xie, Huaying and Luo, Jianzhang and Zeng, Qingyu and He, Feifei and Wang, Liyan},
  title = {Iron-Based Nanoplatforms Achieve Hepatocellular Carcinoma Regression Through a Cascade of Effects},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s479425}
}
Kostenlos starten →